Skip to main content
. 2017 Jun 23;18(7):1348. doi: 10.3390/ijms18071348

Figure 2.

Figure 2

Effect of RUNX1 on the bone morphogenetic protein 9 (BMP9)-induced early osteogenic differentiation of MSCs and MMCs. Cells were infected with Ad-RUNX1 or Ad-siRUNX1, followed by treatment with optimal BMP9-CM. ALP activity was detected by histochemical staining assay and chemiluminescence assay at five days(5D)and seven days(7D).Overexpression of RUNX1 promoted BMP9-induced ALP activity in: C3H10T1/2 (AC); C2C12 (DF); and MEFs (GI). Inhibition of RUNX1 decreased BMP9-induced ALP activity in: C2C12 (JL); and MEFs (MO). ** p < 0.01, as compared with BMP9 group.